Aim: To determine patient knowledge, interest and willingness-to-pay for pharmacogenomics testing in a community pharmacy.
Patients & methods: The link to a cross-sectional, anonymous online survey was distributed to a convenience sample of patients. The contingent valuation method was used to assess willingness-to-pay.
Results: Twenty seven surveys were completed. Eighty one percent of patients were interested in the service, but patients felt that they would be more likely to use the service if insurance covered the cost.
Conclusion: Patients indicated interest in a pharmacogenomics test, but varying levels of willingness-to-pay. Patients may not be able to connect the benefits of testing to their health, justifying further patient education in order to increase the viability of pharmacogenomics testing as a pharmacy service.
Keywords: community pharmacy; patient opinion; personalized medicine; pharmacogenetic testing; pharmacogenomics.